First quadrivalent flu vaccine approved

Traynor, Kate
April 2012
American Journal of Health-System Pharmacy;4/1/2012, Vol. 69 Issue 7, p538
Academic Journal
The article reports the approval of MedImmune's FluMist Quadrivalent intranasal vaccine, the first influenza virus vaccine that protects against four flu strains, by FDA on February 29, 2012. The labeling states that the vaccine is indicated for active immunization against influenza A and B subtype viruses in people through 49 years of age. Also discussed is the inclusion of two distinct lineages of influenza type B viruses, namely Victoria and Yamagata, in the vaccine.


Related Articles

  • 5 ways to fight the flu this year.  // Consumer Reports;Oct2014, Vol. 79 Issue 10, p12 

    The article presents a list of ways to avoid the flu. Topics include details on the quadrivalent shot which protects against the flu strains and influenza B virus, details on the FluMist nasal spray vaccine for children, and the use of the drugs oseltamivir (Tamiflu) and zanamivir (Relenza) to...

  • Quadrivalent LAIV safe and immunogenic in pediatric study.  // Infectious Diseases in Children;May2012, Vol. 25 Issue 5, p6 

    The article discusses a study which showed that the qaudrivalent live-attenuated influenza (Q/LAIV) vaccines has the potential to provide additional protection when trivalent vaccines has a mismatched B virus that is responsible for most of the influenza B disease.

  • Hib shortage did not lead to spikes in disease incidence.  // Infectious Diseases in Children;Sep2012, Vol. 25 Issue 9, p30 

    The article reports on a study which found that deferral of Haemophilus influenza type b vaccine will not increase disease incidence.

  • Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness -- United States, February 2013. Jackson, Lisa; Jackson, Michael L.; Phillips, C. Hallie; Benoit, Joyce; Belongia, Edward A.; Cole, Deanna; Kopitzke, Sarah; Koepel, Tamara A. Kronenwetter; McLean, Huong Q.; Meece, Jennifer K.; Strey, Sandra K.; Sundaram, Maria E.; Vandermause, Mary; Gaglani, Manjusha; Juhee Song; Clipper, Lydia; Kjar, Dean; Robertson, Anne; Murthy, Kempapura; Dunnahoo, Melinda // MMWR: Morbidity & Mortality Weekly Report;2/22/2013, Vol. 62 Issue 7, p119 

    The article discusses updated estimates of the adjusted effectiveness of the seasonal influenza vaccine in the U.S. as of February 2013. Data is based on children and adults enrolled in the U.S. Influenza Vaccine Effectiveness (Flu VE) Network during December 3, 2012 to January 19, 2013. The...

  • Selecting influenza B strains for vaccines continually problematic.  // Infectious Diseases in Children;Apr2010, Vol. 23 Issue 4, p25 

    The article discusses a presentation by Arnold S. Monto, professor of epidemiology at the University of Michigan School of Public Health in Ann Arbor, on the selection of influenza B strain vaccines, presented at the International Congress on Infectious Diseases in Miami, Florida, in March 2010.

  • Quadrivalent influenza vaccine effective against influenza B strains.  // Infectious Disease News;Aug2013, Vol. 26 Issue 8, p18 

    The article discusses findings on the effectiveness of quadrivalent influenza vaccine against the influenza B strains as compared with inactivated influenza vaccine, that references a study published in the "Journal of Infectious Diseases."

  • Intanza 15 μg Intradermal Seasonal Influenza Vaccine. Duggan, Sean T.; Plosker, Greg L. // Drugs & Aging;2010, Vol. 27 Issue 7, p597 

    Intradermal seasonal influenza vaccine delivered by a microneedle injection system (Intanza®) contains inactivated split virion antigens from influenza type A (H1N1 and H3N2) and B strains as recommended annually by the WHO and the EU for the prevention of seasonal influenza. In randomized,...

  • Quadrivalent influenza vaccines get buy-in from pharmacists. Traynor, Kate // American Journal of Health-System Pharmacy;9/1/2013, Vol. 70 Issue 17, p1461 

    This article focuses on the acceptance of quadrivalent influenza vaccines by pharmacists as a tool to protect patients from influenza. According to Tim R. Brown, director of clinical pharmacotherapy at the Center for Family Medicine at Akron General Medical Center, purchasing these vaccines was...

  • Vaccine recommendations for children and youth for the 2015/2016 influenza season. Moore, Dorothy L // Paediatrics & Child Health (1205-7088);Oct2015, Vol. 20 Issue 7, p1 

    The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization for the 2015/2016 influenza season include some important changes: 1. Children and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics